Chiying An Selected Research

Lapatinib (GW572016)

1/2017

Kinase inhibitors of HER2/AKT pathway induce ERK phosphorylation via a FOXO-dependent feedback loop.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Chiying An Research Topics

Disease

3	Ischemic Stroke 01/2019 - 01/2013
2	Type 2 Diabetes Mellitus (MODY) 01/2021 - 01/2009
2	Neuroinflammatory Diseases 01/2019 - 09/2013
2	Neuroendocrine Tumors (Neuroendocrine Tumor) 01/2017 - 01/2017
2	Brain Ischemia (Cerebral Ischemia) 09/2013 - 01/2013
1	Inflammation (Inflammations) 01/2020
1	Colitis 01/2020
1	Ulcerative Colitis 01/2020
1	Central Nervous System Diseases (CNS Diseases) 01/2019
1	Breast Neoplasms (Breast Cancer) 01/2017
1	Neoplasms (Cancer) 01/2017
1	Carcinogenesis 01/2017
1	Insulin Resistance 01/2009

Drug/Important Bio-Agent (IBA)

3	Pharmaceutical PreparationsIBA 01/2020 - 09/2013
3	Neuroprotective AgentsIBA 01/2019 - 01/2013
2	tanshinoneIBA 09/2013 - 01/2013
1	AntidiarrhealsIBA 01/2020
1	Proteins (Proteins, Gene)FDA Link 01/2020
1	Dextran SulfateIBA 01/2020
1	AntioxidantsIBA 01/2020
1	CytokinesIBA 01/2020
1	Messenger RNA (mRNA)IBA 01/2020
1	LDL Receptors (LDL Receptor)IBA 01/2019
1	scutellarinIBA 01/2019
1	MMEIBA 01/2017
1	Capecitabine (Xeloda)FDA Link 01/2017
1	Lapatinib (GW572016)FDA Link 01/2017
1	DNA (Deoxyribonucleic Acid)IBA 01/2017
1	Neprilysin (Neutral Endopeptidase)IBA 01/2017
1	Octreotide (Sandostatin)FDA LinkGeneric 01/2017
1	Somatostatin Receptors (Somatostatin Receptor)IBA 01/2017
1	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 01/2017
1	ErbB Receptors (EGF Receptor)IBA 01/2017
1	AlbuminsIBA 09/2013
1	Bovine Serum AlbuminIBA 01/2013
1	Retinol-Binding Proteins (Retinoid Binding Proteins)IBA 01/2009
1	AdipokinesIBA 01/2009

Therapy/Procedure

2	Therapeutics 01/2021 - 01/2017